[1] Aslam A, Kwo P Y. Epidemiology and disease burden of alcohol associated liver disease[J]. J Clin Exp Hepatol, 2023, 13: 88-102.
[2] Wu M, Qin S, Tan C, et al. Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study[J]. BMC Med, 2023, 21: 277.
[3] Seitz H K, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease[J]. Nat Rev Dis Primers, 2018, 4: 16.
[4] Global status report on alcohol and health 2018[R]. World Health Organization, 2018.
[5] Seitz H K, Neuman M G. The history of alcoholic liver disease: from an unrecognized disease to one of the most frequent diseases in hepatology[J]. J Clin Med, 2021, 10.
[6] Huang D Q, Mathurin P, Cortez-Pinto H, et al. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2023, 20: 37-49.
[7] Åberg F, Jiang Z G, Cortez-Pinto H, et al. Alcohol-associated liver disease-global epidemiology[J]. Hepatology, 2024, 80: 1307-1322.
[8] Amonker S, Houshmand A, Hinkson A, et al. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis[J]. Hepatol Commun, 2023, 7.
[9] Sengupta S, Gill V, Mellinger J L. Alcohol-associated liver disease and public health policies[J]. Hepatology, 2024, 80: 1323-1341.
[10] Wyper G M A, Mackay D F, Fraser C, et al. Evaluating the impact of alcohol minimum unit pricing on deaths and hospitalisations in Scotland: a controlled interrupted time series study[J]. Lancet, 2023, 401: 1361-1370.
[11] Kong L Z, Chandimali N, Han Y H, et al. Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease[J]. Int J Mol Sci, 2019, 20.
[12] Raya Tonetti F, Eguileor A, Mrdjen M, et al. Gut-liver axis: recent concepts in pathophysiology in alcohol-associated liver disease[J]. Hepatology, 2024, 80: 1342-1371.
[13] Purohit V, Bode J C, Bode C, et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium[J]. Alcohol, 2008, 42: 349-361.
[14] Liu S Y, Tsai I T, Hsu Y C. Alcohol-related liver disease: basic mechanisms and clinical perspectives[J]. Int J Mol Sci, 2021, 22.
[15] Fu Y, Maccioni L, Wang X W, et al. Alcohol-associated liver cancer[J]. Hepatology, 2024, 80: 1462-1479.
[16] 中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 等. 酒精性肝病基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19: 990-996.
[17] Moreno C, Mueller S, Szabo G. Non-invasive diagnosis and biomarkers in alcohol-related liver disease[J]. J Hepatol, 2019, 70: 273-283.
[18] Israelsen M, Rungratanawanich W, Thiele M, et al. Non-invasive tests for alcohol-associated liver disease[J]. Hepatology, 2024, 80: 1390-1407.
[19] Narayanan P, Wu T, Shah V H, et al. Insights into ALD and AUD diagnosis and prognosis: exploring AI and multimodal data streams[J]. Hepatology, 2024, 80: 1480-1494.
[20] Nam D, Chapiro J, Paradis V, et al. Artificial intelligence in liver diseases: improving diagnostics, prognostics and response prediction[J]. JHEP Rep, 2022, 4: 100443.
[21] Sheron N. Alcohol and liver disease in Europe-simple measures have the potential to prevent tens of thousands of premature deaths[J]. J Hepatol, 2016, 64: 957-967.
[22] Haque L Y, Leggio L. Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder[J]. Hepatology, 2024, 80: 1408-1423.
[23] Thursz M R, Mullish B H. Alcohol-associated liver disease: Emerging therapeutic strategies[J]. Hepatology, 2024, 80: 1372-1389.
[24] Marek G W, Malhi H. MetALD: Does it require a different therapeutic option?[J]. Hepatology, 2024, 80: 1424-1440.
[25] Simonetto D A, Winder G S, Connor A A, et al. Liver transplantation for alcohol-associated liver disease[J]. Hepatology, 2024, 80: 1441-1461. |
